Related Experiment Video

Updated: Jun 10, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Brachytherapy for cervix cancer: time for change

M A Zahra

    Clinical Oncology (Royal College of Radiologists (Great Britain))
    |August 10, 2010
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Stereotactic Radiosurgery for Gynecologic Cancer
    10:35

    Stereotactic Radiosurgery for Gynecologic Cancer

    Published on: April 17, 2012

    Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy
    11:38

    Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy

    Published on: July 3, 2014

    Related Experiment Videos

    Last Updated: Jun 10, 2026

    Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
    08:34

    Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

    Published on: February 6, 2019

    Stereotactic Radiosurgery for Gynecologic Cancer
    10:35

    Stereotactic Radiosurgery for Gynecologic Cancer

    Published on: April 17, 2012

    Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy
    11:38

    Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy

    Published on: July 3, 2014

    Related Concept Videos

    Treatment Resistent Cancers02:56

    Treatment Resistent Cancers

    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
    Treatment Resistant Cancers02:56

    Treatment Resistant Cancers

    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

    Articles linked to this work by shared authors, journal, and citation graph.

    Intra-tumour genetic heterogeneity and poor chemoradiotherapy response in cervical cancer.

    British journal of cancer·2010

    Concurrent weekly cisplatin chemotherapy and radiotherapy in a haemodialysis patient with locally advanced cervix cancer.

    Clinical oncology (Royal College of Radiologists (Great Britain))·2008

    Quality of Life Endpoints in Advanced Gastrointestinal Cancer Trials: Systematic Review of Inclusion, Challenges, and Implications (2020-2024).

    Clinical oncology (Royal College of Radiologists (Great Britain))·2026

    Patterns and Predictors of Dying at Home for Adults With Primary Malignant Brain Tumours: A Comprehensive National Cohort Analysis.

    Clinical oncology (Royal College of Radiologists (Great Britain))·2026

    Seizure Risk in Patients With Brain Metastases: Interim Analysis From a Prospective Observational Study. Is it Time to Review Driving Policy?

    Clinical oncology (Royal College of Radiologists (Great Britain))·2026

    The Relevance of Cancer-Type-Specific Scenarios in Predicting Primary Radiotherapy Use in Nonmetastatic Cancer Patients in the Netherlands Towards 2032.

    Clinical oncology (Royal College of Radiologists (Great Britain))·2026

    Current Practice for Electronic Medical Device Management in Radiation Therapy.

    Clinical oncology (Royal College of Radiologists (Great Britain))·2026

    The Application of AI in Cancer MDT and its Legal Implication.

    Clinical oncology (Royal College of Radiologists (Great Britain))·2026

    Expanding the Horizon of CAR-T Cell Therapy: Present Obstacles and New Strategies for Future CARs in Solid Tumors.

    Anti-cancer agents in medicinal chemistry·2026

    Radical Hysterectomy for Non-Endometrioid Endometrial Cancer With Cervical Involvement: A Retrospective Cohort Study.

    Journal of surgical oncology·2026

    Ischemic Postconditioning in Patients With Acute Stroke With Successful Recanalization After Endovascular Therapy: A Pilot Randomized Controlled Trial.

    Stroke·2026

    Depth-sensitive optical property characterization using multi-frequency laparoscopic spatial frequency domain imaging.

    Biomedical optics express·2026

    Metabolomic and inflammatory signatures in congenital hypothyroidism: a longitudinal analysis of levothyroxine response.

    Frontiers in endocrinology·2026

    Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG PET/CT) Monitoring of Rapidly Progressive Low-Risk Cutaneous Melanoma: A Case Report of Durable Response to Combined Stereotactic Body Radiotherapy (SBRT) and Immunotherapy.

    Cureus·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us